Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare two commonly used MS medications, IFN β-1a subcutaneous three times per week (Rebif) and oral twice daily dimethyl fumarate (Tecfidera), on mean number of new or enlarging T2 lesions at 6 months in adults with relapsing-remitting multiple sclerosis who are prescribed these medications and receive a 6 month MRI scan as standard of care.
Critère d'inclusion
- Multiple sclerosis